Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | -9.82% | +1.38% | -22.22% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 3.57M | Capitalization | 121M |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -125M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 33.8 x |
P/E ratio 2024 * |
-0.8
x | P/E ratio 2025 * |
-0.78
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.45% |
Latest transcript on Adicet Bio, Inc.
1 day | -9.82% | ||
1 week | +1.38% | ||
Current month | -1.34% | ||
1 month | -31.63% | ||
3 months | -55.05% | ||
6 months | +22.50% | ||
Current year | -22.22% |
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +9.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.47 | -9.82% | 939,720 |
24-05-09 | 1.63 | -1.21% | 440,942 |
24-05-08 | 1.65 | -4.62% | 1,001,437 |
24-05-07 | 1.73 | +2.37% | 1,612,871 |
24-05-06 | 1.69 | +16.55% | 3,099,672 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.22% | 121M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ACET Stock